The Clinical Trial for Evaluation of Efficacy and Safety of DWP05195 in Postherpetic Neuralgia: Double-blind, Placebo-controlled, Randomized, Multi-center, Exploratory Clinical Trial.
Phase of Trial: Phase II
Latest Information Update: 14 Apr 2014
At a glance
- Drugs DWP 05195 (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Daewoong Pharmaceutical
- 20 Feb 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 15 Mar 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 15 Mar 2012 Planned End Date 1 Feb 2013 added as reported by ClinicalTrials.gov.